247 related articles for article (PubMed ID: 16082334)
1. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
2. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
3. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
[TBL] [Abstract][Full Text] [Related]
4. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
[TBL] [Abstract][Full Text] [Related]
6. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
[TBL] [Abstract][Full Text] [Related]
7. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
Suzaki Y; Hamada K; Nomi T; Ito T; Sho M; Kai Y; Nakajima Y; Kimura H
Eur Respir J; 2008 Apr; 31(4):783-9. PubMed ID: 18094012
[TBL] [Abstract][Full Text] [Related]
9. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.
Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A
J Immunol; 2008 Apr; 180(7):4714-21. PubMed ID: 18354195
[TBL] [Abstract][Full Text] [Related]
10. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokines and chemokine receptors during human renal transplant rejection.
Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
[TBL] [Abstract][Full Text] [Related]
12. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
[TBL] [Abstract][Full Text] [Related]
13. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.
Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH
Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162
[TBL] [Abstract][Full Text] [Related]
14. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
[TBL] [Abstract][Full Text] [Related]
15. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of targeting CCR5 in allograft recipients.
Gao W; Faia KL; Csizmadia V; Smiley ST; Soler D; King JA; Danoff TM; Hancock WW
Transplantation; 2001 Oct; 72(7):1199-205. PubMed ID: 11602842
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.
Panzer U; Reinking RR; Steinmetz OM; Zahner G; Sudbeck U; Fehr S; Pfalzer B; Schneider A; Thaiss F; Mack M; Conrad S; Huland H; Helmchen U; Stahl RA
Transplantation; 2004 Nov; 78(9):1341-50. PubMed ID: 15548973
[TBL] [Abstract][Full Text] [Related]
19. Effects of blocking the chemokine receptors, CCR5 and CXCR3, With TAK-779 in a rat small intestinal transplantation model.
Xu H; Firdawes S; Yamamoto A; Zhao Y; Ihara Y; Uehara S; Matsunami K; Otsuka H; Fukuzawa M; Miyagawa S
Transplantation; 2008 Dec; 86(12):1810-7. PubMed ID: 19104427
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
